CCC

CAMBIUM BIO LIMITED

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪5.43 M‬AUD
−0.540AUD
‪−2.26 M‬AUD
‪129.00 K‬AUD
‪11.76 M‬
Beta (1Y)
−36.09

About CAMBIUM BIO LIMITED


CEO
Karolis Rosickas
Headquarters
Paddington
ISIN
AU0000327769
FIGI
BBG00590DQC3
Cambium Bio Ltd. engages in the development and commercialization of regenerative therapies derived from novel processed human platelets. The company is headquartered in Paddington, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of CMB is 0.520 AUD — it has increased by 3.30% in the past 24 hours. Watch CAMBIUM BIO LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange CAMBIUM BIO LIMITED stocks are traded under the ticker CMB.
CMB stock has risen by 10.59% compared to the previous week, the month change is a 4.44% rise, over the last year CAMBIUM BIO LIMITED has showed a 30.00% increase.
CMB reached its all-time high on Apr 26, 1996 with the price of 167.490 AUD, and its all-time low was 0.300 AUD and was reached on Dec 13, 2023. View more price dynamics on CMB chart.
See other stocks reaching their highest and lowest prices.
CMB stock is 10.42% volatile and has beta coefficient of −36.09. Track CAMBIUM BIO LIMITED stock price on the chart and check out the list of the most volatile stocks — is CAMBIUM BIO LIMITED there?
Today CAMBIUM BIO LIMITED has the market capitalization of ‪5.43 M‬, it has increased by 3.66% over the last week.
Yes, you can track CAMBIUM BIO LIMITED financials in yearly and quarterly reports right on TradingView.
CAMBIUM BIO LIMITED is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
CMB net income for the last half-year is ‪−1.14 M‬ AUD, while the previous report showed ‪−1.11 M‬ AUD of net income which accounts for −2.33% change. Track more CAMBIUM BIO LIMITED financial stats to get the full picture.
No, CMB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CMB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CAMBIUM BIO LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CAMBIUM BIO LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CAMBIUM BIO LIMITED stock shows the sell signal. See more of CAMBIUM BIO LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.